Viemed Healthcare sees investments pay off

LAFAYETTE, La. – Viemed Healthcare reported core net revenues of $30.2 million for the first quarter of 2022, an increase of $4.7 million or 18% over the same quarter in 2021.  

Total net revenues for the current quarter were $32.3 million, which included approximately $2.1 million for contact and vaccine tracing services related to the COVID-19 pandemic. 

“The record setting quarter in our core business is a reflection of the momentum we are beginning to see in a post pandemic environment,” said Casey Hoyt, CEO. “Our investments in people, technology and inventory during the pandemic have positioned us extremely well to actively engage with patients, providers, and payors as pandemic restrictions abate. We are invigorated by the increasing opportunities for face-to-face interaction with the people we serve in the coming months.” 

Net income before taxes for the quarter was approximately $2.5 million, and adjusted EBITDA for the quarter was approximately $7.3 million.